Adenoviral Delivery of VEGF 121 Early in Pregnancy Prevents Spontaneous Development of Preeclampsia in BPH/5 Mice
- 1 January 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 57 (1) , 94-102
Abstract
An imbalance in circulating proangiogenic and antiangiogenic factors is postulated to play a causal role in preeclampsia (PE). We have described an inbred mouse strain, BPH/5, which spontaneously develops a PE-like syndrome including late-gestational hypertension, proteinuria, and poor feto-placental outcomes. Here we tested the hypothesis that an angiogenic imbalance during pregnancy in BPH/5 mice leads to the development of PE-like phenotypes in this model. Similar to clinical findings, plasma from pregnant BPH/5 showed reduced levels of free vascular endothelial growth factor (VEGF) and placental growth factor (PGF) compared to C57BL/6 controls. This was paralleled by a marked decrease in VEGF protein and Pgf mRNA in BPH/5 placentae. Surprisingly, antagonism by the soluble form of the FLT1 receptor (sFLT1) did not appear to be the cause of this reduction, as sFLT1 levels were unchanged or even reduced in BPH/5 compared to controls. Adenoviral-mediated delivery of VEGF 121 (Ad-VEGF) via tail vein at embryonic day 7.5 normalized both the plasma-free VEGF levels in BPH/5 and restored the in vitro angiogenic capacity of serum from these mice. Ad-VEGF also reduced the incidence of fetal resorptions and prevented the late-gestational spike in blood pressure and proteinuria observed in BPH/5. These data underscore the importance of dysregulation of angiogenic factors in the pathogenesis of PE and suggest the potential utility of early proangiogenic therapies in treating this disease.Keywords
This publication has 46 references indexed in Scilit:
- Recombinant Vascular Endothelial Growth Factor 121 Infusion Lowers Blood Pressure and Improves Renal Function in Rats With PlacentalIschemia-Induced HypertensionHypertension, 2010
- Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growthNature Medicine, 2009
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- Oxidative Stress Contributes to Soluble Fms-Like Tyrosine Kinase-1 Induced Vascular Dysfunction in Pregnant RatsAmerican Journal of Hypertension, 2009
- Novel Splice Variants of sFlt1 are Upregulated in PreeclampsiaPlacenta, 2009
- The Two Stage Model of Preeclampsia: Variations on the ThemePlacenta, 2009
- A stress-responsive RNA switch regulates VEGFA expressionNature, 2009
- A Novel Human-Specific Soluble Vascular Endothelial Growth Factor Receptor 1Circulation Research, 2008
- MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under HypoxiaPLOS ONE, 2006
- Stabilization of Vascular Endothelial Growth Factor mRNA by Hypoxia-Inducible Factor 1Biochemical and Biophysical Research Communications, 2002